Associate Professor, program lead for ‘health economics’.
Fields of research: Health Economics, Simulation and Modelling, Applied Mathematics, Infectious Diseases, Applied Economics, Biostatistics
Campus: Kensington
Dr Anthony Newall is an Associate Professor in Health Economics at The School of Public Health and Community Medicine (SPHCM), UNSW Australia. He completed his Masters of Public Health (Hons) and PhD at the University of Sydney on the cost-effectiveness (economic evaluation) of vaccination.
His main research area is the economic evaluation of infectious disease prevention strategies, as well as the mathematical modelling and statistical analyses that inform these evaluations. He has over 50 peer-reviewed publications on a range of vaccine preventable diseases, including the epidemiology and cost-effectiveness of prevention strategies for influenza (seasonal and pandemic), pneumococcal disease, rotavirus, and human papillomavirus.
He has been appointed to the World Health Organization (WHO) Roster of Experts in the area of Health Economics by the Director-General of the WHO. He is also an Honorary Fellow at the Australian National Centre for Immunisation Research and Surveillance (NCIRS) and has been a Visiting Scholar at the US National Institutes of Health (NIH).
He has received several awards for his research, including the Bernie J. O’Brien award from the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the prestigious Aileen Plant Memorial Prize, the Dean’s Rising Star Award from the Faculty of Medicine, UNSW. He was also awarded the Young Investigator of the Year in 2008 and 2010 by his School at UNSW based on evidence of significant research impact in public health.
Potential future PhD students interested in mathematical modelling, health economics, cost-effectiveness analysis, economic evaluation, statistical or epidemiological projects should contact via email. The PhD projects avaliable require strong quantitative skills but other types of projects may be avaliable for potential ILP or Masters students.
My Expertise
Epidemiology and cost effectiveness (economic evaluation) of infectious disease prevention.
Publications
Li A, Newall AT, Britt H, MacIntyre CR. The cost and disease burden of pneumonia in general practice in Australia. Vaccine 2012; 30: 830-831
Heywood AE, Newall AT, Gao Z, Wood JG, Breschkin A, Nicholson S, et al. Changes in seroprevalence to hepatitis A in Victoria, Australia: A comparison of three time points. Vaccine 2012;30(42):6020-6. (Impact factor = 3.5)
Newall AT, Jit M, Beutels P. Economic evaluations of childhood influenza vaccination: A critical review. PharmacoEconomics 2012;30(8):647-60.
Newall AT, Dehollain JP, Wood JG. Under-explored assumptions in influenza vaccination models: Implications for the universal vaccination of children. Vaccine 2012;30(39):5776-81.
Liyanage S, Li Q, Zheng Y, Seale H, Crowe P, Newall AT, et al. The Role of Human Papillomaviruses in Esophageal Squamous Cell Carcinoma. Asia Pacific Journal of Clinical Oncology 2013;9:12-28
Jit M, Newall AT, Beutels P. Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies. Hum Vaccin Immunother 2013;9(5): 834-40.
Liyanage S, Segelov E, Garland S, Tabrizi S, Seale H, Crowe P, Dwyer D, Barbour A, Newall AT, et al. The relationship between human papillomavirus and oesophageal squamous cell carcinoma in China - a review of the evidence. Advances in Infectious Diseases 2013;3(1); 17-34.
MacIntyre CR, Wang Q, Seale H, Yang P, Shi W, Gao Z, Rahman B, Zhang Y, Wang X, Newall AT, et al. A Randomised Clinical Trial of Three Options for N95 Respirators and Medical Masks in Health Workers. Am J Respir Crit Care Med 2013;187(9):960-6.
Liyanage SS, Rahman B, Gao Z, Zheng Y, Ridda I, Moa A, Newall AT et al. Evidence for the aetiology of human papillomavirus in oesophageal squamous cell carcinoma in the Chinese population: A meta-analysis. BMJ Open 2013;3(11).
Newall AT, Dehollain JP,Creighton P, Beutels P, Wood JG. Understanding the Cost-Effectiveness of Influenza Vaccination in Children: Methodological Choices and Seasonal Variability PharmacoEconomics 2013;31(8):693-702.
Liyanage SS, Rahman B, Ridda I, Newall AT, Tabrizi SN, Garland SM, Segelov E, Seale H, Crowe PJ, Moa A, MacIntyre CR. The aetiological role of human papillomavirus in oesophageal squamous cell carcinoma: a meta-analysis. PLoS ONE 2013; 8(7): e69238
Muscatello D, Newall AT, Dwyer DE, MacIntyre CR. Mortality attributable to seasonal and pandemic influenza, Australia, 2003 to 2009, using a novel time series smoothing approach. PLoS ONE 2013;8(6):e64734.
Begun M, Newall AT, Marks G, Wood JG. Contact Tracing of Tuberculosis: a Systematic Review of Transmission Modelling Studies. PLoS ONE 2013; 8(9): e72470
Newall AT, Reyes JF, Wood JG et al. Economic evaluations of implemented vaccination programmes: Key methodological challenges in retrospective analyses. Vaccine 2014;32(7):759-65.
Newall AT, Dehollain JP. The cost-effectiveness of influenza vaccination in elderly Australians: An exploratory analysis of the vaccine efficacy required. Vaccine 2014; 32 (12) 1323–1325.
Quinn E, Jit M, Newall, AT. Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination. Expert Rev Pharmacoecon Outcomes Res. 2014;14(3):425-35.
Newall AT, Jit M, Hutubessy R. Are Current Cost-Effectiveness Thresholds for Low-and Middle-Income Countries Useful? Examples from the World of Vaccines. PharmacoEconomics 2014; 32 (6), 525-531
Muscatello D, Amin J, MacIntyre CR, Newall AT, et al. Inaccurate Ascertainment of Morbidity and Mortality due to Influenza in Administrative Databases: A Population-Based Record Linkage Study. PLoS ONE 2014; 9(5), e98446.
Begun M, Newall AT, Marks G, Wood JG. Revisiting Styblo’s law: could mathematical models aid in estimating incidence from prevalence data? Epidemiology and Infection 2015;143(7):1556-65.
Gao Z, Wood JG, Gidding HF, Newall AT, Menzies RI, Wang H, et al. Control of varicella in the post-vaccination era in Australia: A model-based assessment of catch-up and infant vaccination strategies for the future. Epidemiology and Infection. 2015;143(7):1467-76.
Liu B. Heywood A E, Reekie J, Banks E, Kaldor JM, McIntyre P, Newall AT, Macintyre CR. Risk factors for herpes zoster in a large cohort of unvaccinated older adults: a prospective cohort study. Epidemiology and Infection 2015;143(13):2871-81.
Karki S, McIntyre P, Newall AT, MacIntyre CR, Banks E, Liu B. Risk factors for pertussis hospitalizations in Australians aged 45 years and over: A population based nested case-control study. Vaccine. 2015;33(42):5647-53.
Karki S, Gidding HF, Newall AT, McIntyre PB, Liu BC. Risk factors and burden of acute Q fever in older adults in New South Wales: A prospective cohort study. Medical Journal of Australia. 2015;203(11):438.e1-.e6.
Barnes M, Heywood AE, Mahimbo A, Rahman B, Newall AT, MacIntyre CR. Acute myocardial infarction and influenza: A meta-analysis of case-control studies. Heart. 2015;101(21):1738-47.
Dirmesropian S, Wood JG, Macintyre CR, Newall AT. A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly. Human Vaccines and Immunotherapeutics. 2015;11(4):818-25.
Dyda A, MacIntyre CR, McIntyre P, Newall AT, Banks E, Kaldor J, et al. Factors associated with influenza vaccination in middle and older aged Australian adults according to eligibility for the national vaccination program. Vaccine. 2015;33(29):3299-305
Dyda A, MacIntyre CR, Banks E, Kaldor J, Newall AT, McIntyre P, Liu B. Medicare Benefits Schedule data to monitor influenza immunisation in Australian adults. Public Health Res Pract. 2015;25(4):e2541543
Mukerji S, MacIntyre CR, Newall AT. Review of economic evaluations of mask and respirator use for protection against respiratory infection transmission. BMC Infectious Diseases. 2015;15(1).
O’Mahony JF, Newall AT, van Rosmalen J. Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice. PharmacoEconomics. 2015;33(12):1255-68.
Wiseman V, Mitton C, Doyle-Waters MM, Drake T, Conteh L, Newall AT, et al. Using Economic Evidence to Set Healthcare Priorities in Low-Income and Lower-Middle-Income Countries: A Systematic Review of Methodological Frameworks. Health Economics. 2016;25:140-61.
Newall AT, Reyes JF, McIntyre P, Menzies R, Beutels P, Wood JG. Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: Uncertain herd impact on pneumonia critical. Vaccine. 2016;34(3):320-7.
Dirmesropian S, Wood JG, Macintyre CR, Beutels P, Newall AT. Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges. PharmacoEconomics 2016; 34 (8), 723-731
Karki, S., Newall, AT., MacIntyre, C.R., Heywood, A.E., McIntyre, P, Banks, E., Liu, B. Healthcare resource utilisation associated with herpes zoster in a prospective cohort of older Australian adults. PLoS ONE. 2016; 11 (8) e0160446
Mealing N, Hayen A, Newall AT. Assessing the impact of vaccination programs on burden of disease: underlying complexities and statistical methods. Vaccine. 2016; 34 (27), 3022-3029
Newall AT. What do we know about the cost-effectiveness of pneumococcal conjugate vaccination in older adults? Human Vaccines and Immunotherapeutics. 2016; 12(10), 2666-2669
Sparrow, E., Friede, M., Sheikh, M., Torvaldsen, S., Newall, AT. Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications. Vaccine. 34 (45), 5442-5448
Walker L, Newall, AT., Heywood, A.E. Knowledge, attitudes and practices of Australian medical students towards influenza vaccination. Vaccine (in press).
Karki, S., Dyda, A., Newall, AT., Heywood, A.E., MacIntyre C.R., McIntyre, P, Banks, E., Liu, B. Comparison of influenza vaccination coverage between immigrant and Australian-born adults. Vaccine (in press).
Reyes JF, Wood JG, Beutels P, Macartney K, McIntyre P, Menzies R Mealing N, Newall AT. Beyond expectations: post-implementation data shows rotavirus vaccination is likely cost-saving in Australia. Vaccine (in press).
